Advances in Hematology : Impact Factor & More
eISSN: 1687-9112pISSN: 1687-9104
Open AccessShare this on:
Key Metrics
CiteScore 
2.8
H-Index
36
SJR
Q3Hematology
SNIP
0.95
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Advances in Hematology
Advances in Hematology Journal Specifications
| Overview | |
| Publisher | Hindawi |
| Language | English |
| Article Processing Charges | USD 800 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Advances in Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Advances in Hematology
Soluble B‐cell Maturation Antigen in Multiple Myeloma and Correlation With Response to Therapy
- 15 Oct 2025
- Advances in Hematology
Newly Diagnosed High-Risk Multiple Myeloma: Outcomes and Management
- 26 Sep 2025
- Advances in Hematology
Incidence of Typical Neutrophil Count With Fy(a-b-) Status Among Hematology Referrals for Neutropenia at an Urban Safety-Net Hospital
- 16 Sep 2025
- Advances in Hematology
Real-World Safety and Efficacy of Venetoclax in Chronic Lymphocytic Leukemia: A Single-Center Comparative Analysis With Randomized Clinical Trials
- 19 Aug 2025
- Advances in Hematology
Title not available
- 1 Jan 2025
- Advances in Hematology
SGLT2 Inhibitor–Associated Euglycemic Diabetic Ketoacidosis (EDKA) in Hematologic Malignancy Patients: A Case Series
- 1 Jan 2025
- Advances in Hematology
Soluble B‐cell Maturation Antigen in Multiple Myeloma and Correlation With Response to Therapy
- 15 Oct 2025
- Advances in Hematology
Newly Diagnosed High-Risk Multiple Myeloma: Outcomes and Management
- 26 Sep 2025
- Advances in Hematology
Incidence of Typical Neutrophil Count With Fy(a-b-) Status Among Hematology Referrals for Neutropenia at an Urban Safety-Net Hospital
- 16 Sep 2025
- Advances in Hematology
Real-World Safety and Efficacy of Venetoclax in Chronic Lymphocytic Leukemia: A Single-Center Comparative Analysis With Randomized Clinical Trials
- 19 Aug 2025
- Advances in Hematology
Title not available
- 1 Jan 2025
- Advances in Hematology
SGLT2 Inhibitor–Associated Euglycemic Diabetic Ketoacidosis (EDKA) in Hematologic Malignancy Patients: A Case Series
- 1 Jan 2025
- Advances in Hematology
FAQs on Advances in Hematology
How many articles did Advances in Hematology publish last year? 
What is the eISSN & pISSN for Advances in Hematology?
What is Citescore for Advances in Hematology?
What is the H Index for Advances in Hematology ?
What is SNIP score for Advances in Hematology?
What is the SJR for Advances in Hematology?
Who is the publisher of Advances in Hematology?
